Short Interest in NovAccess Global Inc. (OTCMKTS:XSNX) Declines By 52.6%
Short Interest in NovAccess Global Inc. (OTCMKTS:XSNX) Declines By 52.6%
NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a significant decline in short interest in February. As of February 28th, there was short interest totalling 3,600 shares, a decline of 52.6% from the February 13th total of 7,600 shares. Based on an average trading volume of 6,200 shares, the short-interest ratio is currently 0.6 days.
NovAccess Global Price Performance
XSNX stock opened at $0.18 on Friday. The firm has a 50 day simple moving average of $0.19 and a two-hundred day simple moving average of $0.20. NovAccess Global has a one year low of $0.10 and a one year high of $0.60.
Get NovAccess Global alerts:NovAccess Global Company Profile
(Get Rating)
NovAccess Global, Inc is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.
Featured Articles
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- Just the Catalyst NIO Investors Needed
- FuelCell Energy Gains Traction, Shares Surge
- Solo Brands May Remind Investors Why Cash is King
- Someone Is Buying The Dip In MongoDB
- Etsy Stock: Crafty Bargain or Piece of Junk?
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
NovAccess Global Inc.(場外交易代碼:XSNX-GET Rating)2月份空頭股數銷量大幅下降。截至2月28日,空頭股數共有3600股,較2月13日的7600股下降了52.6%。以平均成交量6,200股計算,目前短息比率為0.6天。
NovAccess全球性價比
上週五,XSNX股價開盤報0.18美元。該公司的50日簡單移動均線切入位在0.19美元,200日簡單移動均線切入位在0.20美元。NovAccess Global的一年低點為0.10美元,一年高位為0.60美元。
到達NovAccess全球警報:NovAccess全球公司簡介
(獲取評級)
NovAccess Global,Inc.是一家生物製藥公司,致力於提供癌症和神經疾病的診斷、治療和免疫療法的開發,以治療腦瘤患者。該公司成立於1997年2月25日,總部設在俄亥俄州凱霍加縣。
專題文章
- 免費獲取NovAccess Global(XSNX)上的StockNews.com研究報告
- 蔚來正是投資者所需的催化劑
- FuelCell Energy獲得牽引力,股價飆升
- 獨家品牌可能提醒投資者為什麼現金為王
- 有人在購買MongoDB中的Dip
- Etsy股票:狡猾的討價還價還是垃圾?
接受NovAccess全球日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對NovAccess Global和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧